Pharmaceutical / Healthcare

Dynamic changes in the pharmaceutical and health care sector are caused by the major technological progress. The most important trends, including development of innovative medical therapies, digitalisation, and the use of increasingly more complex and more detailed patient data, as well as focus on diagnostics and prevention, make pharmaceutical companies invest even more in research and development.

The experiences with the COVID-19 pandemic have accelerated some trends on the consumer market, such as digitisation of sales, communication with patients, use of multichannel platforms for promotion and sales, but have also uncovered major challenges to the industry, including risks related to limitations in the supply chain, dependence on some markets and producers, as well as increased importance of cooperation with governmental bodies. Therefore, succeeding on the pharmaceutical market requires skilful use of development opportunities, but also mitigation of major risk factors related to market limitations. 

We provide aid to our Clients in the pharmaceutical sector with their projects to improve their competitive advantage and efficiencies.

Services for pharmaceutical and health care sector include:

• financial audit
• financial audit of their R&D projects
• transaction-related advisory (financial and tax due diligence, completion accounts, transaction support)
• support in accounting policies (e.g., capitalisation of R&D works)
• advisory related to reorganisation and restructuring of business (mergers, spin-offs, group reorganisation)
• business consulting (budget analysis, financial processes analysis and optimisation)
• enterprise valuation (purchase price allocation, impairment tests)
• financial reporting advisory (consolidation, improvement of internal reporting or group reporting)
• support in preparation of the financial statements for the stock exchange (implementation of IFRS standards, drafting of the first financial statements according to IFRS standards, support in drafting the prospectus and first reporting for the stock exchange)
• optimisation of financial reporting (improved transparency for the end user, increasing the information value of the financial statements for investors)